Crossmark

Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test

Crossref DOI link: https://doi.org/10.1007/s12149-021-01700-w

Published Online: 2022-01-01

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miyazaki, Yoshiaki https://orcid.org/0000-0002-5615-7862
Kameyama, Masashi

Nakamizo, Akira

Noguchi, Tomoyuki

Tabata, Nobuyuki
Funding

Funding for this research was provided by:

Nihon Medi-Physics (1, 2)
License Information

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2022-01-01
More Information

Article History

Received: 2 October 2021

Accepted: 17 November 2021

First Online: 1 January 2022

Declarations

:

: MK is listed as an inventor on a patent application (2019–074369, 2017–199618) related to this work submitted by Nihon Medi-Physics to the Japan Patent Office. MK received research funding from Nihon Medi-Physics and Fujifilm Toyama Chemistry, which supply [<sup>123</sup>I] IMP in Japan.

Document is current

Any future updates will be listed below